Author:
Agbavor Bernadette,Agbanyo Abigail,Loglo Aloysius Dzigbordi,Antwi Philemon Boasiako,Ackam Nancy,Adjei Jonathan,Frimpong Venus,Boampong Kwadwo,Frimpong Michael,Addo Matthew Glover,Wansbrough-Jones Mark,Amoako Yaw Ampem,Phillips Richard Odame
Funder
European Commission
European and Developing Countries Clinical Trials Partnership
Kwame Nkrumah University
of Science and Technology
Reference37 articles.
1. Buruli ulcer: history and disease burden;Röltgen,2019
2. Phillips, RO, Saunderson, P, Simpson, H, Deribe, K, and Tabah, EN, Mapping the global distribution of Buruli ulcer: a systematic review with evidence consensus. The Lancet Global Health, 2019. 7(7): p. e912-e922.10.1016/S2214-109X(19)30171-8.
3. Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load;Frimpong;PLoS Negl Trop Dis,2019
4. Buruli ulcer: diagnosis of Mycobacterium ulcerans disease: a manual for health care providers;Portaels,2001
5. Phillips, RO, Robert, J, Abass, KM, Thompson, W, Sarfo, FS, et al., Randomised trial to compare clarithromycin (extended release)-rifampicin and streptomycin-rifampicin for early, limited lesions of M. ulcerans infection. The Lancet, 2020. 395(10232): p. 1259-1267.10.1016/S0140-6736(20)30047-7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bacterial diversity in Buruli ulcer lesions in Ghana;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-08